Literature DB >> 15670022

Low molecular weight heparin for repeated pregnancy loss: is it based on solid evidence?

P G Lindqvist1, J Merlo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15670022     DOI： 10.1111/j.1538-7836.2005.01155.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  4 in total

1.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Heparin rescues factor V Leiden-associated placental failure independent of anticoagulation in a murine high-risk pregnancy model.

Authors:  Jianzhong An; Magarya S Waitara; Michelle Bordas; Vidhyalakshmi Arumugam; Raymond G Hoffmann; Brian G Petrich; Uma Sinha; Paula E North; Rashmi Sood
Journal:  Blood       Date:  2013-01-16       Impact factor: 22.113

Review 3.  Strategies for diagnosis and prevention of venous thromboembolism during pregnancy.

Authors:  Shalini Jain Bagaria; V B Bagaria
Journal:  J Pregnancy       Date:  2011-07-21

4.  Fetal gene defects precipitate platelet-mediated pregnancy failure in factor V Leiden mothers.

Authors:  Rashmi Sood; Mark Zogg; Randal J Westrick; Yi-He Guo; Edward J Kerschen; Guillermina Girardi; Jane E Salmon; Shaun R Coughlin; Hartmut Weiler
Journal:  J Exp Med       Date:  2007-04-16       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.